tirzepatide removed from fda shortage list Lilly's weight-loss drug FDA's FDA Allows Compounded Tirzepatide During
Description
[23] [28] Current clinical guidelines recommend appropriate patient selection and monitoring rather than avoiding these medications based solely on theoretical pancreatic risk in otherwise suitable candidates

Guo et al
The most well-known brand of tirzepatide currently available is Mounjaro and Zepbound , which has been approved by the FDA for the treatment of type 2 diabetes and is widely prescribed for weight loss as well
Additionally, its GLP-1 receptor agonist component has been associated with vasodilation and decreased glomerular hyperfiltration, which could contribute to preserving kidney function

doi: 10.1002/osp4.84